Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticholinergic Drug Use in Patients With Rheumatoid Arthritis and Its Effects on Fracture Risk

NCT06812481 is registered in ClinicalTrials.gov with Balikesir University as lead sponsor.

NCT NCT06812481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06812481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticholinergic Drug Use in Patients With Rheumatoid Arthritis and Its Effects on Fracture Risk
Lead sponsor
Balikesir University
Phase
Observational
Overall status
Recruiting
Start date
September 15, 2025
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticholinergic adverse reaction, fractures, bone, rheumatoid arthritis (ra)